Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Why Recursion Pharmaceuticals (RXRX) Went Up on Monday? [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A (RXRX) 
Company Research Source: Yahoo! Finance
Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other firms that kick off Monday leading gains. The stock market kicked off the week's trading on a positive note, with all main indices finishing in the green territory, as economies took a pause from their tariff war, while investors breathed a sigh of relief on the February retail sales report which didn't come worse. According to the latest figures, retail sales rose 0.2 percent, albeit below the 0.6 percent as expected by analysts. Excluding autos, sales are up by 0.3 percent, in line with economists' expectations. Following the news, the Dow Jones clocked in a 0.85-percent gain, followed by the S&P 500 with 0.64 percent, and the tech-heavy Nasdaq with 0.31 percent. Meanwhile, 10 companies that l Read more
Impact Snapshot
Event Time:
RXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Created with Highstock 5.0.1230sec1m5m10m30m60m90m120m0.00%
Opt-in for RXRX alerts
Opt-in for
RXRX alerts

from News Quantified
Opt-in for
RXRX alerts

from News Quantified